ASPY is now Atrys
ICM is now Atrys
ITMS is now Atrys
AxisMed is now Atrys
Lenitudes is now Atrys
Areas of activity
Research and development (R&D)
Atrys develops different closely related complementary activity areas, such as the area of advanced diagnostic and the translational research.
Atrysis a biomedical company focused on developing new tools for diagnosis and personalized treatment of cancer and precancerous diseases.
The management team consists of scientists and senior managers with a solid career in the field of health. In total, Atrys has now 30 professionals specializing in oncology.
Investors
Atrys offers a section for shareholders and investors with all the information required by the applicable law in this respect, in addition to the information considered relevant for investors.
